10x Genomics, Inc. Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in 10x Genomics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in 10x Genomics, Inc. for January 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 182.78 | 376 | 68,726 | 473,491 | 473.9 K to 473.5 K (-0.08 %) |
| Jan 21 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 181.49 | 900 | 163,343 | 473,867 | 474.8 K to 473.9 K (-0.19 %) |
| Jan 21 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 180.27 | 1,206 | 217,406 | 474,767 | 476 K to 474.8 K (-0.25 %) |
| Jan 21 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 179.28 | 1,608 | 288,285 | 475,973 | 477.6 K to 476 K (-0.34 %) |
| Jan 21 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 178.31 | 1,110 | 197,925 | 477,581 | 478.7 K to 477.6 K (-0.23 %) |
| Jan 21 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 176.57 | 900 | 158,910 | 478,691 | 479.6 K to 478.7 K (-0.19 %) |
| Jan 21 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 175.79 | 1,400 | 246,103 | 479,591 | 481 K to 479.6 K (-0.29 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 141.61 | 100 | 14,161 | 480,991 | 481.1 K to 481 K (-0.02 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 140.94 | 900 | 126,847 | 481,091 | 482 K to 481.1 K (-0.19 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 139.88 | 5,200 | 727,386 | 481,991 | 487.2 K to 482 K (-1.07 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | Sell | S | 138.91 | 1,300 | 180,588 | 487,191 | 488.5 K to 487.2 K (-0.27 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Option Exercise | M | 5.04 | 10,000 | 50,400 | 114,515 | |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 141.91 | 200 | 28,382 | 880,468 | 880.7 K to 880.5 K (-0.02 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 140.83 | 1,523 | 214,486 | 880,668 | 882.2 K to 880.7 K (-0.17 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 139.91 | 6,277 | 878,233 | 882,191 | 888.5 K to 882.2 K (-0.71 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Sell | S | 139.08 | 2,000 | 278,160 | 888,468 | 890.5 K to 888.5 K (-0.22 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | Saxonov Serge | Chief Executive Off ... | Buy | M | 5.04 | 10,000 | 50,400 | 890,468 | 880.5 K to 890.5 K (+1.14 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Option Exercise | M | 5.04 | 10,000 | 50,400 | 470,159 | |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 141.91 | 200 | 28,382 | 20,774 | 21 K to 20.8 K (-0.95 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 140.78 | 1,764 | 248,331 | 20,974 | 22.7 K to 21 K (-7.76 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 139.92 | 6,036 | 844,525 | 22,738 | 28.8 K to 22.7 K (-20.98 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Sell | S | 139.08 | 2,000 | 278,152 | 28,774 | 30.8 K to 28.8 K (-6.50 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Chief Financial Off ... | Buy | M | 5.04 | 10,000 | 50,400 | 30,774 | 20.8 K to 30.8 K (+48.14 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 141.58 | 1,200 | 169,896 | 70,386 | 71.6 K to 70.4 K (-1.68 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 140.62 | 6,825 | 959,744 | 71,586 | 78.4 K to 71.6 K (-8.70 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 139.83 | 22,026 | 3,079,814 | 78,411 | 100.4 K to 78.4 K (-21.93 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | See Remarks | Sell | S | 138.78 | 3,699 | 513,346 | 100,437 | 104.1 K to 100.4 K (-3.55 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 613,000 | |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 141.77 | 400 | 56,708 | 34,608 | 35 K to 34.6 K (-1.14 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 140.74 | 3,135 | 441,211 | 35,008 | 38.1 K to 35 K (-8.22 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 139.89 | 10,465 | 1,463,947 | 38,143 | 48.6 K to 38.1 K (-21.53 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 138.97 | 3,000 | 416,908 | 48,608 | 51.6 K to 48.6 K (-5.81 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 51,608 | 34.6 K to 51.6 K (+49.12 %) |